Effectiveness and safety of follitropin delta in routine clinical practice in the Nordics and Switzerland (the NORSOS study): a prospective non-interventional study

BackgroundFollitropin delta is the first approved human recombinant follicle-stimulating hormone treatment administered through an algorithmic individualized dosing regimen based on body weight and anti-Müllerian hormone (AMH) levels. This study assesses the effectiveness and safety profile of folli...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Anja Pinborg, Negjyp Sopa, Erling Ekerhovd, Stavros I. Iliadis, June Kaspersen, Enrica Gravotta, Alexander Quaas
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2025-09-01
Edice:	Frontiers in Endocrinology
Témata:	follitropin delta in vitro fertilization assisted reproductive technology anti-Müllerian hormone pregnancy ovarian stimulation
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fendo.2025.1613680/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!